In vivo studies have shown that CTLA-4-deficiency in mice causes severe lymphoproliferative disorders, promoting a Th2 phenotype (44) while a Th1 phenotype is required for efficient anti-tumor immunity (45, 46). The gene discussed is CTLA4; the disease is neoplasm.